Geniposide

CAS No. 24512-63-8

Geniposide ( Geniposide )

Catalog No. M13712 CAS No. 24512-63-8

Geniposide is an iridoid glycoside with a variety of biological activities including neuroprotective,anti-diabetic,antiproliferative,and antioxidative activity.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 54 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Geniposide
  • Note
    Research use only, not for human use.
  • Brief Description
    Geniposide is an iridoid glycoside with a variety of biological activities including neuroprotective,anti-diabetic,antiproliferative,and antioxidative activity.
  • Description
    Geniposide is an iridoid glycoside with a variety of biological activities including neuroprotective,anti-diabetic,antiproliferative,and antioxidative activity. Geniposide has been shown to regulate Nrf2 translocation.
  • Synonyms
    Geniposide
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    24512-63-8
  • Formula Weight
    388.37
  • Molecular Formula
    C17H24O10
  • Purity
    >98%(HPLC)
  • Solubility
    Water: 78 mg/mL (200.83 mM); DMSO: 78 mg/mL (200.83 mM)
  • SMILES
    O=C(C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@]3([H])C(CO)=CC[C@]13[H])OC
  • Chemical Name
    Methyl (1R,2S,6S)-9-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-oxabicyclo[4.3.0]nona-4,8-diene-5-carboxylate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhang Y, et al. Neurochem Int. 2015 Apr 13. pii: S0197-0186(15)00063-7.
molnova catalog
related products
  • Isoviolanthin

    Isoviolanthin reduces the migratory and invasive capacities of TGF-β1-treated HCC cells but exhibits no cytotoxic effects on normal live cells, and has potential as a therapeutic agent for the treatment of advanced-stage metastatic HCC.

  • Brr2 Inhibitor C9

    Brr2 inhibitor C9 is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa (a group of progressive retinal degenerative disorders).

  • SGN-2FF

    SGN-2FF is an oral fucosyltransferase inhibitor with antitumor activity.